Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Fabio Chianelli

Recent news which mentions Fabio Chianelli

Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder
Tickers PHRRF
Tags Neurological Disorders News Fabio Chianelli
From Benzinga
Ketamine for Parkinson's Disease, PharmaTher Holdings Announces Grant of U.S. Patent To Cover It
Tickers PHRRF
Tags Market News PHRRF Benzinga
From Benzinga
PharmaTher Provides Business Highlights And Releases Audited Annual Financials
Tickers PHRRF
Tags News Earnings Fabio Chianelli
From Benzinga
PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease
Tickers PHRRF
Tags Benzinga Penny Stocks Cannabis
From Benzinga
Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies
Tickers PHRRF
Tags LTS LOHMANN Therapie/Systeme AG Psychedelics Cannabis
From Benzinga
PharmaTher Receives Notice Of Allowance For U.S. Patent Covering Ketamine For Parkinson's And Motor Disorders Treatment
Tickers PHRRF
Tags Legal News USPTO
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Tickers AGNPF ALID ATAI AWKNF
Tags PHRM RVVTF BETRF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.